83 results
424B3
NDRA
ENDRA Life Sciences Inc.
5 Jun 24
Prospectus supplement
8:20am
not include the reimbursement of certain expenses of the Placement Agent we have agreed to pay. We have also agreed to issue the Placement Agent … ability to protect our intellectual property;
potential changes in the healthcare industry or third-party reimbursement practices;
our ability to comply
424B5
bv8k a298hzm
3 Apr 24
Prospectus supplement for primary offering
5:15pm
424B5
ehv fo0ssb
3 Apr 24
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
6na7lpqu20rkqvyuw
28 Mar 24
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm